Invention Grant
- Patent Title: In-vivo electrochemical impedance spectroscopy (EIS)-based calibration
-
Application No.: US16391666Application Date: 2019-04-23
-
Publication No.: US11844598B2Publication Date: 2023-12-19
- Inventor: Andrea Varsavsky , Fei Yu , Michael E. Miller , Ning Yang
- Applicant: Medtronic MiniMed, Inc.
- Applicant Address: US CA Northridge
- Assignee: Medtronic MiniMed, Inc.
- Current Assignee: Medtronic MiniMed, Inc.
- Current Assignee Address: US CA Northridge
- Agency: Carter, DeLuca & Farrell LLP
- The original application number of the division: US14466138 2014.08.22
- Main IPC: A61B5/0537
- IPC: A61B5/0537 ; A61B5/145 ; A61B5/1468 ; A61B5/00 ; A61M5/158 ; A61B5/0538 ; A61B5/1473 ; A61B5/1495 ; A61B5/1486 ; G01N27/02 ; A61M5/172 ; A61M5/142
Abstract:
Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
Public/Granted literature
- US20190246943A1 IN-VIVO ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS)-BASED CALIBRATION Public/Granted day:2019-08-15
Information query
IPC分类:
